Effectiveness of boosted lopinavir versus boosted atazanavir in HIV-1 infected patients switching to second-line antiretroviral therapy following failure of an NNRTI first line ART in a low/middle-income setting, a retrospective cohort study: the BaLANCe study. (August 2018)